Non-commercial clinical trials (IITs) in the light of the new EU regulation
Non-commercial clinical research often addresses issues arising from treatment practice. In this context, IITs are subject to the same regulatory framework as commercial clinical research. At the seminar “Non-commercial clinical trials (IITs) in consideration of the new EU regulation” held by Akademie Heidelberg on 12 November 2015 in Frankfurt am Main, three of our Clinical […]
Radiation protection in clinical research
Anyone wishing to use radioactive substances or ionizing radiation, including X-rays, on humans for research purposes requires a permit from the German Federal Office for Radiation Protection (BfS). One of ClinTriCare’ Senior Project Leaders took the opportunity to get first-hand information during a BfS training event on the “Approval Procedure for Medical Research” on 08 […]
Successful business year
It is with great pleasure that ClinTriCare looks back on another successful business year. The company was able to grow strongly by expanding its range of services and developing business relationships. On behalf of all employees and consultants, I would also like to thank our clients and business partners for their trust and enjoyable cooperation. […]
Diabetes mellitus – Etiology and therapy
ClinTriCare invited one of its Project Leaders to Berlin to participate in the 50th Annual Meeting of the German Diabetes Society from 13 to 15 May 2015. This year’s conference was themed “Personalized Diabetology. Innovative – individual – sustainable” and provided a forum for about 6,000 participants to discuss new scientific findings on the etiology, […]
New addition to our portfolio of services: Drug supply
ClinTriCare’s range of services now includes the area of drug supply, which plays a central role in the development of drugs and medical devices. This means that, from now on, clients now can also rely on ClinTriCare to competently handle pharmaceutical activities in the context of product development in the pharmaceutical and biotech industries. For […]
Biologicals and biosimilars
“The way is the product” – this was the core message of the presentation on “Biologicals & biosimilars – and the small difference…” held by Professor Hildegard Sourgens, MD, PhD, during a meeting of the German Society for Pharmaceutical Medicine (DGPharMed) on 13 April 2015 in Mannheim before a broad audience. The development and approval […]
Inspection Readiness – Stakeholders, partners and processes
Be ready for inspection at any time! To better prepare their customer projects for this goal, three ClinTriCare Senior Project Leaders informed themselves in various symposia at a conference of the German Society for Pharmaceutical Medicine (DGPharMed) on 30 January 2015 in Frankfurt am Main about options for quality testing and “readiness” in clinical trial […]
Federal Institute for Drugs and Medical Devices: Talk on EU Regulation 536/2014
The new EU Regulation “On Clinical Trials on Medicinal Products for Human Use and Repealing Directive 2001/20/EC” was published on 27 May 2014 and will take effect in about two years. This will fundamentally change all clinical trials procedures, especially because of the introduction of a common European evaluation procedure for clinical trials. One of […]
Happy New Year!
A new year begins… New goals are defined… New projects start… New clients are waiting… Ambitious goals that are difficult to achieve, are often set for the new year. In that case, it is important to stay motivated and not let yourself be dissuaded from your path, even if that path is sometimes rocky. As […]
Merry Christmas 2014
I would like to take this opportunity to wish my employees and consultants, and all clients, business partners and their families a peaceful and happy Christmas, with the hope that we will all be able to face the challenges ahead of us in the coming year with the necessary energy, health and joy. I am […]